Navigation Links


Genta in Medical News

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

...nces, Inc., Celgene Corporation, F. Hoffmann-La Roche Ltd, Genentech, Inc., genta Incorporated, Millennium Pharmaceuticals, Ortho Biotech Products, LP, Seatt...ffmann-La Roche Ltd (Switzerland) II-56 Genentech, Inc. (USA) II-56 genta Incorporated (USA) II-56 Millennium Pharmaceuticals (USA) II-57 Ort...

FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel

...ultidrug-resistant p-glycoprotein. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors

...ars of counsel and service to our Company." About genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients for a global Phas...

Genta to Present at Bio Investor Forum 2007 Conference

...l be archived at the website for two weeks. About genta genta Incorporated is a biopharmaceutical company with a...ated hypercalcemia that is resistant to hydration. genta is partnered with IDIS (http://www.idispharma.com...

Mighty Conqueror Felled by Stomach Cancer

... reached the liver. Lead study author, Robert genta of University of Texas Southwestern genta and his colleagues compared the description of the...nd that the emperor’s lesions were cancerous. genta says,” It was a huge mass from the entrance of his...
Genta in Medical Technology

Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane

...the lifting of this clinical hold. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology

... Advanced Melanoma. (Publication). About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

Genta Receives Key Patent Related to Oral Gallium Compound G4544

... BERKELEY HEIGHTS, N.J., April 14 /PRNewswire/ -- genta Incorporated (Nasdaq: GNTA ) today announced that...ion. Ganite is exclusively marketed in the U.S. by genta and is available to patients outside the U.S. on a "named-patient" basis. About Genta genta Incorporated is a biopharmaceutical company with a...

Specialized Genasense(R) Clinical Trials Featured at AACR Meeting

...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma

...tent/abstract/JCO.2006.06.0483v1 . About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...g statements with respect to business conducted by genta Incorporated. By their nature, forward-looking sta...

FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data

... decision issued in response to an appeal filed by genta in October 2007, CDER acknowledged that complete r...h collection and analysis of existing data in CLL, genta has developed a new clinical trial, and the Compan...ical Oncology (25:1114, 2007). Conference Call genta management will further discuss the current status...

Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights

...ir development." Highlights and updates of the genta programs appear below. Genasense: Clinical and R...y Phase 3/Melanoma: In the third quarter of 2007, genta initiated a confirmatory, Phase 3, randomized, con...ed either alone or in combination with a taxane. genta has now completed clinical trials to evaluate inte...
Genta in Biological News

Napoleon's mysterious death unmasked, UT Southwestern researcher says

...th has been highly scrutinized over the years. Dr. genta and his colleagues, whose research focuses on gast...rs of arsenic poisoning. To find answers, Dr. genta and the other researchers combined current medical... Gastric cancer was more likely at fault, Dr. genta said. Other scholars have recently found that the ...
Genta in Biological Technology

Auditors for Genta Incorporated Express Going Concern Qualification

BERKELEY HEIGHTS, N.J., March 20 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA ) announced today that in its 2007 financial statements included in the Company's Annual Report on Form 10-K, the auditor's opinion contained a "going concern" qualification. NASDAQ's marketplace rules...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...oscapine to be Effective in Prostate Cancer II-55 Fosamax(R) Found Effective in Preventing Bone Loss in Prostate Cancer Patients II-55 genta Unveils Results of Phase II Clinical Trial of Genasense(R) in Prostate Cancer II-55 Cell Therapeutics Reveals Phase 2 Clinical Trial Results o...

Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma

...f 300 patients are expected to enroll in AGENDA. genta will provide a pooled update of blinded data from ...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights

...and partnering opportunities." Highlights of the genta programs appear below. Genasense: The Leading An...g in Clinical Development Genasense in Melanoma: genta is currently enrolling patients with advanced mela...nticancer Activity In other regulatory activity, genta submitted its response to a prior notice from FDA ...

Genta Announces Second Quarter 2008 Financial Results and Conference Call

...008 financial results on Thursday, August 7, 2008. genta management will host a conference call and live au...ternational). The access code for the live call is genta Incorporated. The call will also be webcast live a... conference ID number is 57549066. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane

...nts that have already issued in the United States. genta holds worldwide exclusive licenses to these patent...the lifting of this clinical hold. About Genta genta Incorporated is a biopharmaceutical company with a... lead compound from its DNA/RNA Medicines program. genta is currently recruiting patients to the AGENDA Tri...

Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia

...cology (ASCO) in Chicago on Monday June 2, 2008. genta was notified in March 2008 that its appeal of a "n...the effectiveness of current anticancer treatment. genta is pursuing a broad clinical development program w... to treat various forms of cancer. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs

...y's option, and will be convertible into shares of genta common stock at a conversion rate of 100,000 share...ding days. Certain members of senior management of genta Incorporated participated in this offering. The No...on from registration requirements. About Genta genta Incorporated is a biopharmaceutical company with a...

Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights

... CLL -- Company restructures to conserve cash -- genta will seek buyer for Ganite and terminates c-myb an...ir development." Highlights and updates of the genta programs appear below. Genasense: The Leading A...ug in Clinical Development Genasense in Melanoma: genta is currently enrolling patients with advanced mela...

Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results

...luation of strategic options. The Company will provide updates as more information emerges. Emisphere has six product candidates in Phase I: -- genta Incorporated began a Phase I clinical study of oral gallium in the third quarter of 2007; -- A research partner has conducted Phase I studies of ...
Genta in Biological Dictionary

Antisense

... of antisense ESTs are depicted in white. ... Antisense custom design and synthesis for specific gene silencing, using superior results. ... genta Obtains Orphan Drug Designation for C-Myb Antisense ... We have evaluated the specificity and the variation in activity against human immunod...
Other TagsHereditaryHereditary
(Date:11/29/2009)...ogaForce A-Line Athletic Mat is great. It,s a ver...uthor and physician best known for establishing an... Go to www.yogaforce.com and order the new Mat t... San Francisco, CA (PRWEB) N... the YogaForce newly patented, revolutionary A-Lin...
(Date:11/28/2009)...o affect circadian rhythm, , , FRID...sts that an internal body clock that goes on the f...ar disorder in children. , The finding results... children with bipolar disorder, which can make pe...ldren without the disorder. They linked variations...
(Date:11/27/2009)...re-USNewswire/ -- Considered a highly risky and co...olid organ transplantation is now a life-saving ma... and women who gathered at the Winspear Opera Hous... medical centers around the world to celebrate the...stitute (BRTI), one of the pioneers of solid organ...
(Date:11/27/2009)...ldings has announced that it has become a national...argest nonprofit organizations dedicated to arthri... Delray Beach, FL (Vocus) Novemb...O), a company specializing in the marketing and re... has announced today that is has become a national...
(Date:11/27/2009)...se bilingual coloring books designed for children ...munity to educate - inform parents and children al... Dinosuars to ABC,S and a host of other topics. ,...ovember 27, 2009 -- Today’s children have en...y any hour of the day, but one of the oldest and s...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
(Date:11/24/2009)..., 2009) -- The Wildlife Conservation Society (WCS)...remaining population of Siberian tigers has likely...poaching and habitat loss. , WCS say... what needs to be done to protect remaining popula... The report was released by the Siberian Tiger Mon...
(Date:11/24/2009)...h . , The presence of increased body fat, an...es in the blood, hinders the loss and maintenance ...the University of Navarra conducted by Estbaliz Go...cy. , The project, entitled "A nutrigenetic and ...ody weight and inflammation," examines how the ind...
(Date:11/23/2009)...me of day matters to forest trees dealing with dro...rch team led by Professor Malcolm Campbell, Univer...esearch and colleagues in the department of cell a... Capitalizing on their previous work to decode the...ined how poplar trees use their 45,000 genes to re...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 1Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 3Child burn injuries down significantly 58836 1Child burn injuries down significantly 58836 2Child burn injuries down significantly 58836 3AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 1AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 2
Other Contentsneurologyneurologyneurologyneurologyneurologydeficitdeficitdeficitdeficitdeficitdeficitneurologicneurologicneurologicneurologicneuromaneuromaneurosurgeryneurosurgeryneurosurgeryneurosurgeryneurosisneutropenianeutropenianeutropenianeurosyphilis